The management of patients with presumed cerebral venous thrombosis ha
s been recently modified by magnetic resonance imaging and evidence th
at heparin decreases mortality and morbidity. No large consecutive ser
ies of patients with cerebral venous thrombosis has been reported sinc
e then. The aim of our study was to determine the prognosis factors of
patients with cerebral venous thrombosis. Demographic, clinical and r
adiological characteristics were recorded in a homogeneous series of 1
8 consecutive patients with cerebral venous thrombosis collected over
a 31-month period. All patients were treated by heparin at the acute s
tage. We found no difference in demographic, clinical and radiological
characteristics of the patients according to the 1-month and 6-month
outcome. We only found a tendancy towards a better 1-month outcome in
younger patients (p=0.06) and in patients with an isolated intracrania
l hypertension (2p=0.06). A long therapeutic delay might be a factor o
f poor prognosis which might be hidden by a better spontaneous outcome
in patients with isolated intracranial hypertension in whom the diagn
ostic delay is longer. A multicentric study allowing a multivariate an
alysis may therefore be useful to identify prognosis factors in patien
ts with cerebral venous thrombosis.